{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:22:24Z","timestamp":1794273744122,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:00:00Z","timestamp":1794268800000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371575"],"award-info":[{"award-number":["82371575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304505"],"award-info":[{"award-number":["82304505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Province Excellent Research and Innovation Team Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psoriasis is a chronic inflammatory skin disorder driven by epidermal hyperplasia, immune infiltration, and pathological angiogenesis. PAP\u20111, a selective Kv1.3 channel blocker, exhibits therapeutic potential, though its underlying mechanisms remain incompletely understood. Here, we show that both preventive and therapeutic administration of PAP\u20111 markedly attenuates imiquimod (IMQ)-induced psoriasis\u2011like skin lesions and reduces splenomegaly in male rats. RNA sequencing revealed that PAP-1 downregulated genes associated with inflammation and angiogenesis, accompanied by decreased levels of pro-inflammatory cytokines and vascular markers. PAP-1 also inhibited VEGF-A-induced HUVEC proliferation, migration, invasion, and tube formation. Mechanistically, PAP-1 not only blocked Kv1.3 currents, but also suppressed Kv1.3 expression in the skin of IMQ-induced psoriasis-like male rats and VEGF-A-induced HUVECs. Cryo-EM structural analysis revealed that PAP-1 binds within the central cavity of Kv1.3, beneath the selectivity filter, in an inactivated state. These results establish that preventive and therapeutic PAP-1 alleviates psoriasis-like dermatitis via dual anti-inflammatory and anti-angiogenic mechanisms, supporting its further therapeutic development.<\/jats:p>","DOI":"10.1038\/s42003-026-10718-7","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:34:04Z","timestamp":1784529244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Kv1.3 blocker PAP\u20111 alleviates psoriasis\u2011like dermatitis in rats via suppressing inflammation and angiogenesis"],"prefix":"10.1038","volume":"9","author":[{"given":"Feng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renpeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-5558","authenticated-orcid":false,"given":"Sanling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-900X","authenticated-orcid":false,"given":"Changlin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-7601","authenticated-orcid":false,"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"10718_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"C Griffiths","year":"2021","unstructured":"Griffiths, C., Armstrong, A. W., Gudjonsson, J. E. & Barker, J. Psoriasis. Lancet 397, 1301\u20131315 (2021).","journal-title":"Lancet"},{"key":"10718_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/bjd\/ljad399","volume":"190","author":"X Xie","year":"2024","unstructured":"Xie, X. et al. A critical role of the endothelial S-phase kinase-associated protein 2\/phosphatase and tensin homologue axis in angiogenesis and psoriasis. Br. J. Dermatol. 190, 244\u2013257 (2024).","journal-title":"Br. J. Dermatol."},{"key":"10718_CR3","first-page":"e245","volume":"3","author":"A Luengas-Martinez","year":"2023","unstructured":"Luengas-Martinez, A., Ismail, D., Paus, R. & Young, H. S. Inhibition of vascular endothelial growth factor-A downregulates angiogenesis in psoriasis: A pilot study. Ski. Health Dis. 3, e245 (2023).","journal-title":"Ski. Health Dis."},{"key":"10718_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/exd.14790","volume":"32","author":"K Hayakawa","year":"2023","unstructured":"Hayakawa, K., Maeda, T., Egusa, C., Okubo, Y. & Harada, K. Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition. Exp. Dermatol. 32, 878\u2013888 (2023).","journal-title":"Exp. Dermatol."},{"key":"10718_CR5","doi-asserted-by":"publisher","first-page":"111923","DOI":"10.1016\/j.intimp.2024.111923","volume":"132","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis. Int. Immunopharmacol. 132, 111923 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"10718_CR6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1208\/s12248-017-0094-4","volume":"19","author":"C Soderstrom","year":"2017","unstructured":"Soderstrom, C. et al. Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and Skin. AAPS J. 19, 1218\u20131222 (2017).","journal-title":"AAPS J."},{"key":"10718_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","volume":"41","author":"F Severin","year":"2022","unstructured":"Severin, F. et al. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. J. Exp. Clin. Cancer Res. 41, 64 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10718_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31285-5","volume":"13","author":"P Selvakumar","year":"2022","unstructured":"Selvakumar, P. et al. Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators. Nat. Commun. 13, 3854 (2022).","journal-title":"Nat. Commun."},{"key":"10718_CR9","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/med.21800","volume":"41","author":"\u0160 Gubi\u010d","year":"2021","unstructured":"Gubi\u010d, \u0160 et al. Discovery of K(V) 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges. Med. Res. Rev. 41, 2423\u20132473 (2021).","journal-title":"Med. Res. Rev."},{"key":"10718_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/mol.105.015669","volume":"68","author":"A Schmitz","year":"2005","unstructured":"Schmitz, A. et al. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol. Pharmacol. 68, 1254\u20131270 (2005).","journal-title":"Mol. Pharmacol."},{"key":"10718_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","volume":"55","author":"S Kundu-Raychaudhuri","year":"2014","unstructured":"Kundu-Raychaudhuri, S., Chen, Y. J., Wulff, H. & Raychaudhuri, S. P. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis-xenograft model. J. Autoimmun. 55, 63\u201372 (2014).","journal-title":"J. Autoimmun."},{"key":"10718_CR12","doi-asserted-by":"crossref","unstructured":"Jabeen, M. et al. Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12, 789 (2020).","DOI":"10.3390\/pharmaceutics12090789"},{"key":"10718_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41421-021-00269-y","volume":"7","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Structures of wild-type and H451N mutant human lymphocyte potassium channel KV1.3. Cell Discov. 7, 39 (2021).","journal-title":"Cell Discov."},{"key":"10718_CR14","doi-asserted-by":"crossref","unstructured":"Tyagi, A. et al. Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug. Proc. Natl. Acad. Sci. USA. 119, e2113536119 (2022).","DOI":"10.1073\/pnas.2113536119"},{"key":"10718_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13555-021-00662-1","volume":"12","author":"J Nowowiejska","year":"2022","unstructured":"Nowowiejska, J. et al. Assessment of life quality, stress and physical activity among patients with psoriasis. Dermatol. Ther. (Heidelb.) 12, 395\u2013406 (2022).","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10718_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ad.2022.07.021","volume":"114","author":"K Nabieva","year":"2023","unstructured":"Nabieva, K. & Vender, R. Quality of life and body region affected by psoriasis: A systematic review. Actas Dermosifiliogr. 114, 33\u201338 (2023).","journal-title":"Actas Dermosifiliogr."},{"key":"10718_CR17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jid.2022.01.002","volume":"142","author":"Q Yin","year":"2022","unstructured":"Yin, Q. et al. Lidocaine ameliorates psoriasis by obstructing pathogenic CGRP signaling\u2012mediated sensory neuron\u2012dendritic cell communication. J. Invest. Dermatol. 142, 2173\u20132183.e6 (2022).","journal-title":"J. Invest. Dermatol."},{"key":"10718_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114455","volume":"14","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis. EMBO Mol. Med. 14, e14455 (2022).","journal-title":"EMBO Mol. Med."},{"key":"10718_CR19","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. (Baltim., Md.: 1950) 182, 5836\u20135845 (2009).","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"10718_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jdermsci.2004.05.008","volume":"35","author":"K Kawashima","year":"2004","unstructured":"Kawashima, K. et al. Evaluation of cell death and proliferation in psoriatic epidermis. J. Dermatol. Sci. 35, 207\u2013214 (2004).","journal-title":"J. Dermatol. Sci."},{"key":"10718_CR21","doi-asserted-by":"publisher","first-page":"116947","DOI":"10.1016\/j.jep.2023.116947","volume":"318","author":"RM Kamal","year":"2024","unstructured":"Kamal, R. M. et al. GC-MS analysis and the effect of topical application of essential oils of Pinus canariensis C.Sm., Cupressus lusitanica Mill. and Cupressus arizonica Greene aerial parts in Imiquimod-Induced Psoriasis in Mice. J. Ethnopharmacol. 318, 116947 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"10718_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00011-019-01238-8","volume":"68","author":"C Cataldi","year":"2019","unstructured":"Cataldi, C. et al. Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors. Inflamm. Res. 68, 557\u2013567 (2019).","journal-title":"Inflamm. Res."},{"key":"10718_CR23","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3390\/ijms23084457","volume":"23","author":"T Tashiro","year":"2022","unstructured":"Tashiro, T. & Sawada, Y. Psoriasis and systemic inflammatory disorders. Int J. Mol. Sci. 23, 4457 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"10718_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A. & Chiricozzi, A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 55, 379\u2013390 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10718_CR25","doi-asserted-by":"publisher","first-page":"110480","DOI":"10.1016\/j.intimp.2023.110480","volume":"121","author":"D Fu","year":"2023","unstructured":"Fu, D. et al. Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod. Int. Immunopharmacol. 121, 110480 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"10718_CR26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00109-021-02073-3","volume":"99","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Soluble IL-6R-mediated IL-6 trans-signaling activation contributes to the pathological development of psoriasis. J. Mol. Med. (Berl). 99, 1009\u20131020 (2021).","journal-title":"J. Mol. Med. (Berl)."},{"key":"10718_CR27","doi-asserted-by":"publisher","first-page":"116809","DOI":"10.1016\/j.jep.2023.116809","volume":"317","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14\/SOCS3\/STAT3 axis. J. Ethnopharmacol. 317, 116809 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"10718_CR28","doi-asserted-by":"publisher","first-page":"e0180762","DOI":"10.1371\/journal.pone.0180762","volume":"12","author":"EJ Tarcha","year":"2017","unstructured":"Tarcha, E. J. et al. Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial. PLoS One 12, e0180762 (2017).","journal-title":"PLoS One"},{"key":"10718_CR29","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/bph.15407","volume":"178","author":"MA Olivencia","year":"2021","unstructured":"Olivencia, M. A. et al. K(V) 1.3 channels are novel determinants of macrophage-dependent endothelial dysfunction in angiotensin II-induced hypertension in mice. Br. J. Pharmacol. 178, 1836\u20131854 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"10718_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/bjd.20940","volume":"186","author":"A Luengas-Martinez","year":"2022","unstructured":"Luengas-Martinez, A., Paus, R. & Young, H. S. Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis. Br. J. Dermatol. 186, 782\u2013791 (2022).","journal-title":"Br. J. Dermatol."},{"key":"10718_CR31","doi-asserted-by":"publisher","first-page":"21264","DOI":"10.1073\/pnas.0907550106","volume":"106","author":"HB Schonthaler","year":"2009","unstructured":"Schonthaler, H. B., Huggenberger, R., Wculek, S. K., Detmar, M. & Wagner, E. F. Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis. Proc. Natl. Acad. Sci. USA 106, 21264\u201321269 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10718_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/IJPM.IJPM_862_15","volume":"60","author":"N Chawla","year":"2017","unstructured":"Chawla, N., Kataria, S. P., Aggarwal, K., Chauhan, P. & Kumar, D. Significance of vascular endothelial growth factor and CD31 and morphometric analysis of microvessel density by CD31 receptor expression as an adjuvant tool in diagnosis of psoriatic lesions of skin. Indian J. Pathol. Microbiol. 60, 189\u2013195 (2017).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10718_CR33","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1002\/cbin.11448","volume":"44","author":"H Hou","year":"2020","unstructured":"Hou, H. et al. An effective method of isolating microvascular endothelial cells from the human dermis. Cell Biol. Int. 44, 2588\u20132597 (2020).","journal-title":"Cell Biol. Int."},{"key":"10718_CR34","doi-asserted-by":"publisher","first-page":"175276","DOI":"10.1016\/j.ejphar.2022.175276","volume":"933","author":"J Tang","year":"2022","unstructured":"Tang, J. et al. Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Eur. J. Pharmacol. 933, 175276 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"10718_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/cells9040913","volume":"9","author":"M Lasch","year":"2020","unstructured":"Lasch, M. et al. Contribution of the potassium channels K(V)1.3 and K(Ca)3.1 to smooth muscle cell proliferation in growing collateral arteries. Cells 9, 913 (2020).","journal-title":"Cells"},{"key":"10718_CR36","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10557-014-6554-5","volume":"28","author":"P Cidad","year":"2014","unstructured":"Cidad, P. et al. K+ channels expression in hypertension after arterial injury, and effect of selective Kv1.3 blockade with PAP-1 on intimal hyperplasia formation. Cardiovasc. Drugs Ther. 28, 501\u2013511 (2014).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10718_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/mol.110.064014","volume":"78","author":"PI Zimin","year":"2010","unstructured":"Zimin, P. I. et al. Potassium channel block by a tripartite complex of two cationophilic ligands and a potassium ion. Mol. Pharmacol. 78, 588\u2013599 (2010).","journal-title":"Mol. Pharmacol."},{"key":"10718_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nchembio.1271","volume":"9","author":"S Marzian","year":"2013","unstructured":"Marzian, S. et al. Side pockets provide the basis for a new mechanism of Kv channel-specific inhibition. Nat. Chem. Biol. 9, 507\u2013513 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"10718_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10787-023-01198-w","volume":"31","author":"Y Shahine","year":"2023","unstructured":"Shahine, Y. et al. Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8\/NF-\u03baB\/micro RNA-31, AKT\/mTOR\/P70S6K milieu, and Tregs\/Th17 balance. Inflammopharmacology 31, 1341\u20131359 (2023).","journal-title":"Inflammopharmacology"},{"key":"10718_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"10718_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10718_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. J. Chem. Inf. Model 61, 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model"},{"key":"10718_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput Chem."},{"key":"10718_CR44","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI membrane builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput. Chem."},{"key":"10718_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10718-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10718-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10718-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:43:28Z","timestamp":1794271408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10718-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10718"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10718-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1497"}}